Inbio Ventures

investment firm

About

Inbio Ventures is a venture capital firm that seeks to invest early stage and startups

Details

Founded date
Jan 1, 2013
Operating Status
Active
Investor Type
Venture Capital

We are the ambitious team of professionals with comprehensive experience in academic and biopharmaceutical industry, drug discovery and development, venture investments. We are supported by the Advisory Board of internationally recognized KOLs in various therapeutic areas. We are dedicated to investing in breakthrough drug development projects worldwide.

Investments

Number of Investments
Number of Lead Investments
15
1
Inbio Ventures has made 15 investments. Their most recent investment was on Dec 5, 2017, when Neon Therapeutics raised $36M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $36M Bioinformatics
Series B $70M Bioinformatics
Series C $20M Biotechnology
Jul 12, 2016 TransMedics
Private Equity(PE) $12.50M Health Care
May 26, 2016 TransMedics
Series F $51.20M Health Care Yes

Employee Profiles

Number of Employee Profiles
1
Inbio Ventures has 1 current employee profiles, including Executive Andrei Petrov
Executive

Exits

Inbio Ventures has had 8 exits. Inbio Ventures most notable exits include TransMedics ,   Neon Therapeutics

Date Company Name Exit Type Industry
May 1, 2019 TransMedics IPO Health Care Detail
Jun 26, 2018 Neon Therapeutics M&A Bioinformatics Detail
Apr 23, 2018 Argos Therapeutics M&A Biotechnology Detail
Nov 2, 2017 Allena Pharmaceuticals IPO Biotechnology Detail
Jan 27, 2017 Jounce Therapeutics M&A Biotechnology Detail